54 107
Pill imprint 54 107 has been identified as Lithium carbonate 300 mg.
Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania; cluster headaches and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy.
Lithium 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Lithium carbonate Images
- Imprint:
-
54 107
- Strength:
- 300 mg
- Color:
- Beige
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium stearate
povidone
sodium chloride
sodium lauryl sulfate
sorbitol
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roxane Laboratories, Inc.
- National Drug Code (NDC):
- 00054-0021
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0412 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Lithium Carbonate resources
- Lithium
- Lithium (Wolters Kluwer)
- Lithium Controlled-Release and Extended-Release Tablets (Wolters Kluwer)
- Lithium Syrup (Wolters Kluwer)
- lithium (Cerner Multum)
- lithium (Micromedex) - Includes Dosage Information
- Lithium Salts (AHFS DI)
- Lithane (FDA)
- Lithium (FDA)
- Lithium Capsules (FDA)
- Lithium Carbonate (FDA)
- Lithium Carbonate Tablets (FDA)
- Lithium Citrate Syrup (FDA)
- Lithium ER (FDA)
- Lithium Oral Solution (FDA)
- Lithium (Wolters Kluwer)
Search Again
